Chapter 25 - Immunotherapy and Cancer Therapeutics: A Rich Partnership
References (0)
Cited by (3)
Treatment strategies in cancer from past to present
2018, Drug Targeting and Stimuli Sensitive Drug Delivery SystemsAdministration strategies for proteins and peptides
2014, International Journal of PharmaceuticsCitation Excerpt :The revolution of biotechnology has led to the creation of various types of therapeutic proteins (Brown, 2005; Xie et al., 2008; Almeida and Souto, 2007; Tan and Danquah, 2012; Stevenson et al., 2012; Ye et al., 2010; Torchilin and Lukyanov, 2003), with the potential to provide treatment for certain dangerous diseases that have long been thought incurable (Brown, 2005). Biotherapy now has the potential to target chronic and malignant diseases such as cancer (Dougan and Dranoff, 2012; Jaffee, 1999; Chen et al., 2013; Rossi et al., 2013a), dwarfism (Matiasevic and Gershberg, 1966), AIDS (Tomasselli and Heinrikson, 2000), autoimmune disorders (Almeida and Souto, 2007), etc. Moreover, proteins can be used to detect and diagnose diseases (Gelfand, 2001; Hj, 1983) in addition to using proteins as vaccines in order to ensure protection from various diseases (Rossi et al., 2013b; Chura-Chambi et al., 2014).
Mesoporous silica nanoparticles doped with gold nanoparticles for combined cancer immunotherapy and photothermal therapy
2019, ACS Applied Bio Materials